CXCR4/CXCL12 expression and signalling in kidney cancer.
about
Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinomaRenal Cancer Stem Cells: Characterization and Targeted TherapiesCurrent approaches in identification and isolation of human renal cell carcinoma cancer stem cellsCXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brainStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisCXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrityCXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cellsChemokines as therapeutic targets in renal cell carcinomaThe role of CXC chemokines in pulmonary fibrosis.Brain metastasis-initiating cells: survival of the fittest.Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.Molecular imaging of metastatic potential.Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targetingBreast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma.Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stromaStromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasisTargeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatmSDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaStromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal CancerAntileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells.Role of chemokines in tumor growth.Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis.Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients.The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.Human cytomegalovirus infection inhibits CXCL12- mediated migration and invasion of human extravillous cytotrophoblasts.Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectumHistone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migrationNo common denominator for breast cancer lymph node metastasisInvasive characteristics of human prostatic epithelial cells: understanding the metastatic process.CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway.A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Role of eotaxin-1 signaling in ovarian cancer
P2860
Q24803472-809A5CFE-ECED-46C0-B285-AFBE49D98CC6Q26746970-2FE34004-58B6-41FF-902A-3E7F43F414A9Q26786047-B3743331-145C-4002-A254-8DC5F37D11CCQ27009526-519AA4E1-0429-495B-B3F1-C9B87EAEE872Q28260997-A9458CBB-3B7C-44E0-9528-C985DBC2B3F1Q28572654-AA8C2482-EFFA-47AC-952C-530F244BBF4BQ30408881-7E2B8D7B-8758-4249-B243-5D8337154694Q30435873-3FE0109B-6029-4279-A1C9-32AD2A66EA4DQ30443091-E4A8C310-02A8-45FD-B203-4DA57532E3E3Q33755959-98028388-6926-44FF-8336-1AFFD7623442Q33814898-59EF4B0D-FF53-44C4-935D-002486DBF2F6Q33917943-3AED75C3-1169-4707-9044-97503853120BQ33964919-9C836E45-7948-4ED9-B3B0-265293018DB4Q34010429-C032E263-21C8-4EFD-A5DE-D4F8B61FBEE1Q34025696-2ED28147-0CE1-4EBB-BDDF-6E4C21B52420Q34357222-EE8D8112-C145-4C74-B9DA-CD4925270AECQ34463556-0A8D9F2E-8615-4087-A1FB-650EBC49003FQ35088166-42D2288F-83C5-4B44-B8E2-A4BA67F465ACQ35131138-75BE5965-5C0F-4F74-89CD-5AFE209A519BQ35213463-05B9029F-21E9-408D-AA91-27B01D9F0684Q35566338-4D1E73B8-3F1D-422B-9919-E03492F620E9Q35576488-F2C2B2DD-3422-438B-8A0C-9BBC639E89CBQ35742364-04244256-2433-44D8-A143-6A49A393E583Q35813085-8888F74C-2CC7-4309-BB25-0A236EE324EEQ35836868-22B67FAE-3D0E-4B48-88A9-1ECA9076522AQ36012911-DD57DF0C-D872-4B5A-AD1C-A4960566ED37Q36120825-77491529-F56F-415C-B8B5-B02F05858023Q36175129-887CF02B-1770-42AD-ADDF-05624C7231ABQ36225000-62C2289B-BD0F-43D5-AA67-79CA329EE7EDQ36318564-B70502A5-93C9-4F8F-A36B-4419BBCD353EQ36338510-360AE16D-6511-48CC-AC46-8570539ADB52Q36535867-122065ED-BAF4-4A29-995B-B29CC635DD11Q36579500-0E033390-B85D-4BC1-B071-A9372141213CQ36608727-C774F461-3BEB-4C3E-B3ED-8E80BF67ECE4Q36615425-F314D44B-CAA5-4836-81D9-27FCF0DEBCB2Q36617032-7B77FAFF-AC97-4388-B1C4-2B8E023AF568Q36675171-2C912C1E-EB4B-4C88-9C06-F84C3185D12DQ36977544-623C6FE6-086A-4C56-852E-1FBADD41BE6AQ37089440-37CE967C-71DC-4227-99AB-8D3671D303F0Q37160334-A3181AC6-1EAA-48FA-9C08-A21E50BBEA2A
P2860
CXCR4/CXCL12 expression and signalling in kidney cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CXCR4/CXCL12 expression and signalling in kidney cancer.
@ast
CXCR4/CXCL12 expression and signalling in kidney cancer.
@en
CXCR4/CXCL12 expression and signalling in kidney cancer.
@nl
type
label
CXCR4/CXCL12 expression and signalling in kidney cancer.
@ast
CXCR4/CXCL12 expression and signalling in kidney cancer.
@en
CXCR4/CXCL12 expression and signalling in kidney cancer.
@nl
prefLabel
CXCR4/CXCL12 expression and signalling in kidney cancer.
@ast
CXCR4/CXCL12 expression and signalling in kidney cancer.
@en
CXCR4/CXCL12 expression and signalling in kidney cancer.
@nl
P2093
P2860
P356
P1476
CXCR4/CXCL12 expression and signalling in kidney cancer.
@en
P2093
A J Schrader
J Atzpodien
K E J Dittmar
M Probst-Kepper
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600221
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1011389076